Addus HomeCare (ADUS) to Release Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) is expected to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of $1.35 per share and revenue of $291.04 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $113.22 on Monday. Addus HomeCare has a 12-month low of $85.94 and a 12-month high of $136.72. The firm’s fifty day moving average price is $126.04 and its 200 day moving average price is $127.12. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of 25.91, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 in the last 90 days. 4.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Addus HomeCare currently has an average rating of “Buy” and an average price target of $134.22.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.